Authors: Kreklau, EL Limp-Foster, M Liu, NL Xu, Y Kelley, MR Erickson, LC

Citation: El. Kreklau et al., A novel fluorometric oligonucleotide assay to measure O-6-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase, NUCL ACID R, 29(12), 2001, pp. 2558-2566

Authors: Zhang, QW Ohannesian, DW Kreklau, EL Erickson, LC

Citation: Qw. Zhang et al., Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O-6-methylguanine DNA methyltransferase mRNA, J PHARM EXP, 298(1), 2001, pp. 141-147

Authors: Kreklau, EL Liu, NL Li, ZH Cornetta, K Erickson, LC

Citation: El. Kreklau et al., Comparison of single- versus double-bolus treatments of O-6-benzylguanine for depletion of O-6-methylguanine DNA methyltransferase (MGMT) activity invivo: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity, J PHARM EXP, 297(2), 2001, pp. 524-530

Authors: Kreklau, EL Carlson, EJ Drewett, JG

Citation: El. Kreklau et al., Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation, MOL C ENDOC, 153(1-2), 1999, pp. 103-111

Authors: Kreklau, EL Kurpad, C Williams, DA Erickson, LC

Citation: El. Kreklau et al., Prolonged inhibition of O-6-methylguanine DNA methyltransferase in human tumor cells by O-6-benzylguanine in vitro and in vivo, J PHARM EXP, 291(3), 1999, pp. 1269-1275